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Introduction: This study aims at comparing the very short-term effects of conventional and noisy (variable)
pressure support ventilation (PSV) in mechanically ventilated patients with acute hypoxemic respiratory failure.
Methods: Thirteen mechanically ventilated patients with acute hypoxemic respiratory failure were enrolled in this
monocentric, randomized crossover study. Patients were mechanically ventilated with conventional and noisy
PSV, for one hour each, in random sequence. Pressure support was titrated to reach tidal volumes approximately
8 mL/kg in both modes. The level of positive end-expiratory pressure and fraction of inspired oxygen were kept
unchanged in both modes. The coefficient of variation of pressure support during noisy PSV was set at 30%.
Gas exchange, hemodynamics, lung functional parameters, distribution of ventilation by electrical impedance
tomography, breathing patterns and patient-ventilator synchrony were analyzed.
Results: Noisy PSV was not associated with any adverse event, and was well tolerated by all patients. Gas
exchange, hemodynamics, respiratory mechanics and spatial distribution of ventilation did not differ significantly
between conventional and noisy PSV. Noisy PSV increased the variability of tidal volume (24.4 ± 7.8% vs.
13.7 ± 9.1%, P <0.05) and was associated with a reduced number of asynchrony events compared to conventional
PSV (5 (0 to 15)/30 min vs. 10 (1 to 37)/30 min, P <0.05).
Conclusions: In the very short term, noisy PSV proved safe and feasible in patients with acute hypoxemic
respiratory failure. Compared to conventional PSV, noisy PSV increased the variability of tidal volumes, and was
associated with improved patient-ventilator synchrony, at comparable levels of gas exchange.
Trial registration: ClinicialTrials.gov, NCT00786292Introduction
Mechanical ventilation is often used as a lifesaving inter-
vention to restore or maintain adequate oxygenation in
critical ill patients. However, mechanical ventilation per
se can induce or aggravate pulmonary damage, a condi-
tion known as ventilator-induced lung injury (VILI) [1].
It has been shown that early restitution of spontaneous
breathing activity is associated with benefits regarding
pulmonary function as well as decreased need for* Correspondence: mgabreu@uniklinikum-dresden.de
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reproduction in any medium, provided the orvasopressors or sedative drugs in patients with acute
respiratory failure [2]. Early induction of spontaneous
breathing may lead to faster weaning of the patient from
mechanical ventilation and therefore shorten the length
of stay in the intensive care unit or in the hospital.
Pressure support ventilation (PSV) is one of the most
common modes of assisted spontaneous breathing [3].
During PSV, spontaneous breaths are supported by a
fixed pressure support, which may result in a respiratory
pattern with relatively low tidal volume variability [4].
However, decreased variability of tidal volumes has been
shown to be associated with impaired lung function and
increased lung damage [5-7]. Experimental studies have
demonstrated that the combination of assisted spontaneousLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pressure support levels (variable pressure support ventila-
tion - noisy PSV) may improve lung function and reduce
pulmonary inflammatory response [8-10]. Interestingly,
the ‘optimal’ level of pressure support variability is
very close to the respiratory variability seen in healthy
subjects [11,12].
Noisy PSV can increase the variability of the respira-
tory pattern even when it is intrinsically reduced, as
often seen in critically ill patients [13,14]. However, noisy
PSV has been tested only in experimental models of
acute respiratory distress syndrome (ARDS). Thus, we
designed this study to test the safety and feasibility of
noisy PSV in patients with acute hypoxemic respiratory
failure. We hypothesized that, in the short term, noisy
PSV would result in comparable lung function and
better patient comfort than conventional PSV, proving
safe for clinical use.
Material and methods
Study design
This monocenter, randomized crossover study was
approved by the institutional ethics review board of the
University Hospital Dresden, Germany (EK 276112007)
and registered at ClinicialTrials.gov (NCT00786292).
Thirteen patients from the anesthesiological and surgical
intensive care units of the University Hospital Dresden
who were diagnosed with acute hypoxemic respiratory
failure were enrolled in this study. Written informed
consent was obtained from patient’s legal representative.
Patients were included in the study if all of the following
criteria were fulfilled: a) age between 18 and 75 years;
b) ratio of arterial partial pressure of oxygen and inspired
oxygen fraction (PaO2/FIO2) between 150 and 300 mmHg;
total duration of mechanical less than 14 days; mechanical
ventilation with biphasic positive airway pressure ventila-
tion with at least 20% of minute ventilation corresponding
to spontaneous breathing, or assisted mechanical ven-
tilation with pressure support ventilation, at time of
inclusion. Patients were excluded from the study if at least
one of the following criteria was present: i) body mass
index > 35; ii) esophageal disease; iii) neuromuscular dis-
ease; iv) instable thorax; v) pneumothorax; brain injury/in-
creased intracranial pressure; vi) brain tumor; vii) agitation;
viii) increased need for vasopressors or hemodynamic drug
support, defined as dopamine or dobutamine dosage >
5 μg/kg/min, noradrenaline > 2 μg/kg/min, or use of vaso-
pressin or milrinone; ix) chronic pulmonary disease; x)
acute coronary insufficiency; xi) participation in other clin-
ical trials in the preceding four weeks.
The study intervention was mechanical ventilation
with conventional or variable PSV for one hour each in
all patients, in a randomized fashion. One of two enve-
lopes containing either conventional or variable PSVwas drawn to determine the sequence of mechanical
ventilation modes.
After preparing the measurement devices, patients
were switched to the study ventilator and a stabilization
period of 20 minutes was allowed prior to baseline
measurements. Following baseline measurements, the
sequence of conventional and noisy PSV was random-
ized and the patients were ventilated for one hour with
each mode. The study was interrupted if one of the fol-
lowing criteria was fulfilled: 1) acute change of mental
status; 2) diaphoresis; 3) exacerbated movement of inter-
costal muscles; 4) dyspnea; 5) paradoxical abdominal
breathing; 6) respiratory rate >30/min or <6/min; g) ar-
terial pH <7.30; 7) heart rate increase >20% compared to
baseline, or <50/min, or >110/min (absolute); 8) mean
arterial pressure (MAP) increase >20% compared to
baseline, or <70 mmHg, or >110 mmHg (absolute).
After finishing the study protocol, patients were
switched back to their initial ventilator and therapy was
continued at the discretion of the treating physician.
Monitoring and instrumentation
All patients were monitored with electrocardiography,
pulse oxymetry and invasive arterial blood pressure
measurement according to the current standard of the
intensive care units. Additionally, an esophageal balloon
catheter (Erich Jäger, Höchberg, Germany) and electrical
impedance tomography (EIT Evaluation Kit II, Dräger
Medical, Lübeck, Germany) were used for study specific
measurements in case of the absence of contraindica-
tions to these procedures. Epidemiological data, current
therapy and diagnosis were reviewed and captured using
the intensive care units’ electronic patient data manage-
ment system (ICM, Dräger Medical).
Mechanical ventilation
All patients were already on assisted spontaneous
breathing prior to the start of the study, and laid in the
supine and semirecumbent 45° position. A commercial in-
tensive care ventilator (Dräger Evita XL, Dräger Medical)
was used for both PSV and noisy PSV. To perform noisy
PSV, the ventilator was remote controlled by an external
computer using the Dräger MediBus protocol as previ-
ously described [10]. During noisy PSV, pressure support
values were generated randomly and followed a Gaussian
(normal) distribution, whereby the coefficient of variation
(100 × standard deviation (SD)/mean value) was 30%, as
described in detail in a previous study from our group
[12]. The ventilator settings and alarm limits are defined
in Table 1. Briefly, pressure support was titrated to reach
tidal volumes (VT) of approximately 8 ml/kg ideal body
weight. We chose that level since it represents the upper
limit of VT still compatible with protective ventilation.
The level of positive end-expiratory pressure (PEEP) and
Table 1 Ventilator settings
Settings PSV Noisy PSV
Respiratory rate Spontaneous Spontaneous
PASB (driving pressure) Targeted at VT ≈ 8 mL/kg Targeted at VT ≈ 8 mL/kg
PEEP According to current therapy According to current therapy
Ramp 0.20 0.20
FIO2 According to current therapy According to current therapy
Flow trigger 3 L/min 3 L/min
Coefficient of variation of pressure support 0% 30% (normal distribution of randomly generated values)
Alarm limits
Peak airway pressure 35 cm H2O 35 cm H2O
Minute ventilation ± 50% of current therapy ± 50% of current therapy
Respiratory rate (lower) 6 6
Respiratory rate (higher) 30 30
PSV, pressure support ventilation; VT, tidal volume; PEEP, positive end-expiratory pressure; FIO2, inspiratory oxygen fraction.
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according the current therapy. The flow trigger was set at
3 L/min and cycling-off criteria at 25% of peak inspiratory
flow in all patients, for both conventional and noisy PSV.
Measurements
Gas exchange variables (PaO2/FIO2; arterial partial
pressure of carbon dioxide (PaCO2)) were measured by
point of care blood gas analysis (ABL800, Radiometer,
Copenhagen, Denmark). Hemodynamic variables (heart
rate (HR), MAP) were recorded from the hemodynamic
monitoring system. Airway flow signals were conti-
nuously recorded from the mechanical ventilator at a
sample frequency of 125 Hz using the MediBus interface
to calculate VT by means of numerical integration of the
flow signal over time. Airway (peak and mean airway
pressures (Paw peak, Paw mean)) and esophageal pres-
sures were measured, digitized and recorded using previ-
ously described routines [15]. EIT was used to measure
relative changes in thoracic impedance as a surrogate for
the spatial distribution of ventilation. EIT data was
recorded and stored in the device and processed offline
using a routine developed by our group. The transpul-
monary pressure (PL) was calculated as the difference
between airway and esophageal pressure. Pressure time
product (PTP) was calculated by numerical integration
of esophageal pressure and inspiratory time. The coeffi-
cient of variation of VT (CV VT) was calculated as the
ratio of the standard deviation and the mean of VT.
Patient-ventilator asynchrony was assessed from respira-
tory signals and quantified as described elsewhere [16].
Briefly, we computed the occurrence of ineffective trig-
gering (single patient effort fails to trigger the ventilator
and hence no pressure support is delivered), double
triggering (ventilator triggered twice without an expi-
ration between cycles), as well as double inspiratoryeffort (patient had two inspiratory efforts, just one effort
triggered the ventilator), and values were added to
obtain the total number of asynchrony events.
Statistical analysis
Values are given as mean and SD unless stated other-
wise. Differences between noisy and conventional PSV
were tested using paired t tests, or Wilcoxon signed-rank
test, as appropriate. EIT data were compared using re-
peated measures two-way analysis of variance (ANOVA)
(factors: group and region) with Bonferroni adjustment.
All tests were performed using GraphPad Prism (Version
5a, GraphPad Software, La Jolla, CA, USA). Statistical
significance was accepted at P <0.05.
Results
We enrolled eleven male and two female patients, whose
demographic and clinical data are summarized in Table 2.
Both, PSV and noisy PSV were feasible and could be
safely applied in all patients. We did not find any signs
of distress or discomfort associated with mechanical
ventilation in this study. Furthermore, we could not
identify any negative effects of noisy PSV on gas ex-
change, hemodynamics or respiratory variables associ-
ated with the application of variable pressure support
levels. Accordingly, the interruption criteria were not
fulfilled during conventional or noisy PSV. Major vari-
ables of hemodynamics (HR, MAP) and gas exchange
(PaO2/FIO2, PaCO2) (Figure 1A-C), as well as acid/base
status (pH, HCO3
- , base excess (BE), lactate) (Table 3)
did not differ significantly between PSV and noisy PSV.
Pressure support levels (Δ pressure) and airway pres-
sures (peak, mean and transpulmonary pressure) as well
as pressure time product (PTP) and minute ventilation
did not differ significantly between groups (Figure 2A-F).
CV VT was significantly higher with noisy PSV, as compared
Table 2 Demographics
Patient number Age IBW (kg) Duration of
ventilation







1 55 66 9 TC 6 0.45 None Sufentanil 228 4 12 Acute bowel ischemia
2 48 70 2 ETT 10 0.40 Propofol Sufentanil 217 4 3 Acute peritonitis
3 22 48 3 ETT 12 0.50 Midazolam Sufentanil 157 4 7 Pneumonia
4 56 68 4 ETT 10 0.40 None Sufentanil 279 2 3 Pneumonia
5 41 57 5 ETT 10 0.40 Midazolam Sufentanil 240 4 9 Sepsis
6 19 75 14 TC 10 0.45 Clonidin Sufentanil 240 2 4 Lung contusion
7 72 78 6 ETT 10 0.45 None Sufentanil 298 4 7 Perforated aortic aneurysm
8 69 75 11 TC 10 0.40 None Sufentanil 165 2 7 Pneumonia
9 74 71 9 ETT 10 0.80 None Sufentanil 165 3 7 Perforated aortic aneurysm
10 34 75 10 TC 10 0.45 Clonidin Sufentanil 221 3 2 Lung contusion
11 18 82 8 ETT 12 0.40 Midazolam Sufentanil 188 4 10 Pneumonia
12 73 71 5 ETT 12 0.40 None Sufentanil 203 5 9 Lung contusion
13 60 70 2 ETT 8 0.40 Propofol Sufentanil 248 2 7 Anastomotic insufficiency
Summary counts or
mean and min-max
49.3 (18-74) 69.7 (48-82) 6.8 (2-14) 4 × TC 10 (6-12) 0.45 (0.40-0.80) 6 × none 13 × sufentanil 219 (157-298) 3.3 (2-5) 6.7 (2-12) 7 × direct
9 × ETT 3 × midazolam 6 × indirect
2 × propofol
2 × clonidin













Figure 1 Hemodynamics and gas exchange. Hemodynamics and gas exchange during (conventional) pressure support ventilation (PSV) and
noisy (variable) PSV. (A) Heart rate (HR); (B) mean arterial blood pressure (MAP); (C), ratio of arterial partial pressure of oxygen and inspired
oxygen fraction (PaO2/FIO2); (D) arterial partial pressure of carbon dioxide (PaCO2).
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lowest VT values were lower, while the highest VT values
were higher than during conventional PSV (Table 3).
Accordingly, the range of VT values during noisy PSV
(11.3 ± 4.9 mL/kg) was higher than during conventional
PSV (7.3 ± 5.0 mL/kg, P < 0.01).Table 3 Blood and respiratory variables
Baseline (PSV) PSV Noisy PSV
pH 7.41 ± 0.13 7.41 ± 0.05 7.41 ± 0.05
HCO3
- (mmol/L) 27.1 ± 4.0 27.1 ± 3.8 27.2 ± 3.8
BE 3.0 ± 3.9 2.9 ± 3.8 3.0 ± 3.8
Lactate (mmol/L) 1.2 ±0.4 1.0 ± 0.3 1.1 ±0.3
Lowest VT/kg IBW (mL/kg) 4.6 ± 2.3 5.3 ± 2.3 3.0 ± 1.6**
Mean VT/kg IBW (mL/kg) 9.0 ± 1.8 9.0 ± 1.3 8.7 ± 1.3
Highest VT/kg IBW (mL/kg) 13.1 ± 5.8 12.6 ± 3.4 14.3 ± 4.0*
RR (/min) 18.8 ± 6.0 18.9 ± 7.0 19.0 ± 6.4
Ti/Ttot 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
Values are mean ± standard deviation (SD). PSV, pressure support ventilation;
BE, base excess; VT/kg IBW, tidal volume per kg of ideal body weight;
RR, respiratory rate, TI/Ttot, ratio of inspiratory time to total breath duration.
Statistical significance according to Wilcoxon paired, two-sided signed rank
test between PSV and noisy PSV at P <0.05. *, P <0.05; **, P <0.01.Noisy PSV was associated with a decreased number of
asynchrony events compared to conventional PSV
(Figure 3B).
Mean values of VT, mean respiratory rate (RR) and
mean ratio of inspiratory time to total time of the breath-
ing cycle (Ti/Ttot) did not differ significantly between
assisted ventilation modes (Table 3). Also, the regional
distribution of ventilation was comparable during noisy
and conventional PSV (Figure 3C).Discussion
The main findings of the present study were that, in a
mixed population of patients with acute hypoxemic
respiratory failure: 1) noisy PSV was not associated with
adverse events; 2) gas exchange, hemodynamics, mean
respiratory variables and regional distribution of ventila-
tion did not differ significantly between conventional
and noisy PSV; 3) noisy PSV was associated with signifi-
cantly higher tidal volume variability than conventional
PSV; 4) noisy PSV was associated with improved
patient-ventilator synchrony compared to conventional
PSV.
Figure 2 Respiratory variables. Respiratory variables during (conventional) pressure support ventilation (PSV) and noisy (variable) PSV. (A) Mean
pressure support (Δ pressure); (B) peak airway pressure (Paw peak); (C) mean airway pressure (Paw mean); (D) peak transpulmonary pressure
(PL peak); (E) pressure time product (PTP); (F) minute ventilation (MV).
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trial on noisy PSV in patients. Since this was a safety
and feasibility study, we focused on patients with mild to
moderate acute hypoxemic respiratory failure, who were
already mechanically ventilated with conventional PSV
and had no major comorbidities. Also, we performed
noisy PSV for a very short period of time in order to
minimize potential risks. It is worth noting that none of
the patients disclosed any sign of discomfort associated
with the application of noisy PSV. Accordingly, no major
changes in hemodynamics were observed during noisyPSV, suggesting that the new mode of assisted mechan-
ical ventilation was well tolerated. Furthermore, noisy
PSV was well accepted by the nursing and medical
personnel.
The use of assisted mechanical ventilation in acute
respiratory failure has been intensively debated in recent
years. Papazian and colleagues [17] showed that the use
of neuromuscular blocking agents and consecutive
controlled mechanical ventilation within the first 48 h
could reduce mortality of patients with severe, but not
mild or moderate ARDS. In contrast, the risk of muscle
Figure 3 Variability, patient-ventilator asynchrony and regional distribution of ventilation. Variability, patient-ventilator asynchrony, and
distribution of regional ventilation by electrical impedance tomography (EIT) during (conventional) pressure support ventilation (PSV) and noisy
(variable) PSV. (A) coefficient of variation of tidal volume (CV VT); (B) asynchrony events; (C) percentage of ventilation assessed by electrical imped-
ance tomography (EIT); *, P <0.05 vs. PSV. Data in panel A and C are presented as mean and standard deviation (SD), data in panel B as median
and range. Two-way analysis of variance (ANOVA), paired t tests and Wilcoxon signed-rank tests were used as appropriate.
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diaphragm, has been reported even after short periods of
controlled mechanical ventilation [18]. Also, it has been
demonstrated that the induction of spontaneous breathing
even in the early phase of ARDS can be beneficial in terms
of reduced use of sedatives, vasopressors and reduced time
on mechanical ventilation [19]. Those discrepancies may
be explained by distinct transpulmonary pressures during
different modes of mechanical ventilation.
It is worth noting that the transpulmonary pressure,
which is the driving force leading to re-opening of
collapsed lung regions, can be higher during assisted
than controlled mechanical ventilation, especially in
gravitationally dependent lung regions [19]. Since during
ARDS the transpulmonary pressure gradient is increased
along the ventral-dorsal axis [20], such effect may play a
pivotal role for recruitment of dependent zones. On the
other hand, excessive transpulmonary pressures may
contribute to ventilator-associated lung injury [21]. In
our patients, the mean transpulmonary pressures were
comparable between conventional and noisy PSV,
suggesting that the new mode of assisted mechanical
ventilation did not pose this population at higher risk of
lung injury.It is well known that intrinsic variability in many organ
systems is decreased during disease and the aging
process [14,22]. However, it is not known whether the
restoration of variability of organ rhythm, for example of
VT in mechanically ventilated patients, is beneficial. A
growing body of laboratory evidence suggests that
variable mechanical ventilation modes aiming at imi-
tating physiological respiratory variability improve gas
exchange and respiratory system mechanics, and reduce
ventilator-associated lung injury [5,6,9]. Interestingly, the
type of variability, that is natural (recorded from healthy
subjects) or random (generated randomly by a computer),
seems not to play a major role for the beneficial effects of
variable ventilation [23]. On the other hand, observational
clinical studies suggested that increased variability of
respiratory variables is associated with faster weaning
from mechanical ventilation [24]. Even though our pa-
tients showed a considerable amount of variability in
respiratory variables during conventional PSV, such vari-
ability, as measured by the coefficient of variation, roughly
doubled during noisy PSV, reaching values described for
healthy subjects [11].
Since the level of pressure support largely determines
VT [10], the finding that during noisy PSV the lowest VT
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higher than during conventional PSV is not unexpected.
Although the highest VT values during noisy PSV is
outside the protective range of 4 to 8 mL/kg, they occur
only rarely, due to the Gaussian distribution of the
pattern underlying the new mode of mechanical ventila-
tion. Furthermore, experimental evidence has shown that
variable ventilation with extreme VT as high as 16 mL/kg
and as low as 1.6 mL/kg occurring once every 20 to 30
minutes is associated with decreased ventilator lung
histologic damage compared to non-variable ventilation
with constant VT of 6 mL/kg [5]. In addition, one should
keep in mind that during noisy PSV, VT values more pro-
tective than during conventional PSV also occurred in our
population.
Different modes of assisted mechanical ventilation may
lead to increased variability of respiratory variables in the
clinical practice, most notably proportional assist ventila-
tion (PAV) and neurally adjusted ventilator assist (NAVA).
However, in contrast to PAV and NAVA, noisy PSV is able
to restore the breath-by-breath variability of the respira-
tory pattern independent of a patient’s intrinsic respiratory
variability. Thus, noisy PSV may increase the variability of
the breathing pattern even in patients with reduced intrin-
sic variability, for example due to sedation or impairment
of the respiratory center. Furthermore, noisy PSV does
not require closed-loop mechanisms, rendering it technic-
ally simpler to implement and easier to handle compared
to PAV and NAVA. Also, noisy PSV does not require
insertion of esophageal catheters, making it attractive for
patients with a contraindication for such catheters, and is
devoid of movement artifacts.
In experimental models of the ARDS, noisy PSV led to
an important improvement in arterial oxygenation com-
pared to PSV [9,10,25]. In contrast, in our patients, the
PaO2 did not differ significantly between conventional
and noisy PSV. There are several possible explanations
for the lack of improvement in gas exchange: 1) the time
period under noisy PSV was relatively short; 2) our
patients had less severe hypoxemic respiratory failure
than previous models of ARDS; 3) the hypoxic pulmonary
vasoconstriction was blunted. In experimental models of
ARDS, redistribution of pulmonary blood flow toward
better aerated lung tissue has been observed during noisy
PSV [10], but may have been impaired in our patients, who
were investigated later in the course of respiratory failure.
The distribution of regional ventilation in our patients
did not differ significantly during PSV and noisy PSV.
This finding is in agreement with previous laboratory
data of our group showing that noisy PSV does not
result in recruitment of dependent lung zones [8,10].
However, it must be kept in mind that since EIT is a
cross-sectional technique, the present results cannot be
extrapolated to the whole lungs.Even though the total number of asynchrony events
was relatively low during both modes of assisted mech-
anical ventilation, it is somewhat surprising that patient-
ventilator synchrony was higher during noisy compared
to conventional PSV. Improved synchrony has been well
documented during assisted mechanical ventilation modes
that apply pressure support proportionally to the inspira-
tory effort, like PAV and NAVA [26,27]. However, during
noisy PSV, pressure support is dissociated from the ins-
piratory effort, as shown by our group in experimental
ARDS [10]. A possible explanation is that the variation of
pressure support covered much of the patients’ needs in
terms of fluctuations of tidal volumes, and that patients
adapt rapidly to breath-by-breath changes in pressure
support. Accordingly, it could be speculated that part of
the patient-ventilator asynchrony with conventional
modes of assisted mechanical ventilation, most notably
conventional PSV, originates in their inability to achieve
higher variable respiratory patterns. Certainly, this issue
deserves further investigation.Limitations
This study has several limitations. First, it was designed
as a randomized crossover study aimed at testing the
safety and feasibility, as well as physiological effects, of
the newly developed ventilator mode noisy PSV. There-
fore, we did not obtain long-term information or clinic-
ally relevant outcome variables. Second, since most of
our patients were classified as moderate acute hypox-
emic respiratory failure, the effects of noisy PSV in
severe or mild as well as lung-healthy patients remain to
be determined. Third, we investigated a selected popula-
tion of patients, mainly in the postoperative period, and
our results cannot be extrapolated to other situations.
Fourth, we did not compare noisy PSV with other modes
capable of increasing the variability of the breathing
pattern, namely NAVA and PAV. Fifth, noisy PSV was
performed with a coefficient of variation of 30% in pres-
sure support in all patients, which resulted in a similar
coefficient of variation in VT. Thus, possible individual
needs may have been overlooked. However, such coeffi-
cient of variation has been shown to deliver the best
compromise between gas exchange and lung mechanics
in a model of ARDS [12]. Sixth, patient-ventilator asyn-
chrony events have been registered from respiratory
signals, including esophageal pressure. Thus, we were
not able to quantify the asynchrony between the electric
activation of the diaphragm and pressure support
cycling-in and cycling-off. Furthermore, the counts of
events could not be made in a blinded fashion, since
tracings from noisy PSV and PSV differ considerably, and
the mechanisms for such findings could not be addressed.
Thus, our findings are indicative of an association.
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Noisy PSV proved safe and feasible in a population of
patients with mild to moderate acute hypoxemic respira-
tory failure in the short term. Compared to conventional
PSV, noisy PSV increased the variability of tidal volumes,
and was associated with improved patient-ventilator syn-
chrony, at comparable levels of gas exchange.
Key messages
 Noisy PSV proved safe and feasible in patients with
hypoxemic acute respiratory failure
 Noisy PSV increased the variability of tidal volumes
compared to conventional PSV
 Noisy PSV was associated with better patient-
ventilator synchrony than conventional PSV
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